Rules and Regulations

Latest Issue of OR Manager
March 2025
Home Regulations/Legal > Rules and Regulations

FDA issues warning letters to endoscope manufacturer

Editor's Note The Food and Drug Administration (FDA) on January 10 announced that it had recently issued two warning letters to Olympus Medical Systems Corporation and one of its subsidiaries, Aizu Olympus Co, Ltd, after facility inspections. The letters addressed violations related to medical device reporting (MDR) requirements and quality…

Read More

By: Judy Mathias
January 12, 2023
Share

The Joint Commission raises healthcare equity standard to NPSG

Editor's Note The Joint Commission on January 10 announced that it had elevated the Leadership (LD) Standard LD.04.03.08, which addresses healthcare disparities as a quality and safety priority, to a National Patient Safety Goal (NPSG), effective July 1, 2023. Current requirements for accreditation will not change, and the intent behind…

Read More

By: Judy Mathias
January 11, 2023
Share

FDA: Class I recall of Arrow central venous access and catheter kits

Editor's Note The Food and Drug Administration (FDA) on December 16 identified the recall by Teleflex and Arrow International, LLC, of its Arrow MAC Two-Lumen Central Venous Access Kits and Arrow Pressure Injectable Arrowg+ard Blue Plus Three-Lumen Central Venous Catheter (CVC) Kits as Class I, the most serious. The recall…

Read More

By: Judy Mathias
January 4, 2023
Share

The Joint Commission announces standards reductions, revisions for 2023

Editor's Note The Joint Commission announced on December 21 that they are eliminating 168 standards (14%) and revising 14 other standards across its accreditation programs in the new year. The Joint Commission additionally announced that it will not raise accreditation fees for domestic hospitals in the coming year due the…

Read More

By: Bridget Brown
December 29, 2022
Share

Sponsored Message

FDA: Exela Pharma Sciences, LLC, expands recall of Sodium Bicarb

Editor's Note The Food and Drug Administration (FDA) on November 29 posted Exela Pharma Sciences’ expansion of its recall of Sodium Bicarbonate Injection, USP, 8.4%, 50 mEq/50 mL vial, 20-count carton. The product poses a safety concern because of vial breakage with flying glass when pressurized while preparing the product for…

Read More

By: Judy Mathias
December 12, 2022
Share

Federal judge declines challenge to vaccination mandate by 14 states

Editor's Note A federal judge in Louisiana declined a case brought by 14 states that challenged the Biden administration’s mandate requiring COVID-19 vaccination for eligible staff at healthcare facilities participating in Medicare and Medicaid Programs, the December 8 Becker’s Hospital Review reports. The states have 60 days to appeal the…

Read More

By: Judy Mathias
December 8, 2022
Share

Sponsored Message

The Joint Commission joins White House pledge to decarbonize healthcare

Editor's Note The Joint Commission announced on December 7 that it was recognized by the Department of Health and Human Services at the 2022 United Nations Climate Change Conference for its actions to decarbonize the healthcare sector and make healthcare facilities more resilient to climate change. The Joint Commission formally…

Read More

By: Judy Mathias
December 8, 2022
Share

CMS releases safety expectations on workplace violence

Editor's Note  The Centers for Medicare & Medicaid Services (CMS) released a new memorandum on November 28 emphasizing the importance of enforcing regulations and expectations to create a safe environment for hospital staff when delivering patient care, the American Hospital Association reported on November 28. According to the memo, the…

Read More

By: Bridget Brown
November 29, 2022
Share

FDA: Class I recall of Baxter Hillrom WatchCare IMS for RF interference risk

Editor's Note The Food and Drug Administration, on November 23, identified the recall by Baxter Hillrom of its WatchCare Incontinence Management System (IMS) as Class I, the most serious. The recall was initiated because of the risk for radiofrequency (RF) emissions from WatchCare devices that may interfere with other devices,…

Read More

By: Judy Mathias
November 29, 2022
Share

FDA: Class I recall of Insulet Omnipod DASH PDM

Editor's Note The Food and Drug Administration (FDA) on November 16 identified the recall by Insulet of its Omnipod DASH Insulin Management System Personal Diabetes Manager (PDM) as Class I, the most serious. The recall was initiated because of PDM battery issues, including: Battery swelling Fluid leakage from the battery…

Read More

By: Judy Mathias
November 17, 2022
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat